ClinVar Miner

Submissions for variant NM_024079.5(ALG8):c.544C>T (p.Gln182Ter)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Center For Human Genetics And Laboratory Diagnostics, Dr. Klein, Dr. Rost And Colleagues RCV003484554 SCV004229111 likely pathogenic Polycystic liver disease 3 with or without kidney cysts 2023-08-14 criteria provided, single submitter clinical testing
Fulgent Genetics, Fulgent Genetics RCV005003653 SCV005631817 likely pathogenic ALG8 congenital disorder of glycosylation; Polycystic liver disease 3 with or without kidney cysts 2024-02-22 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004757592 SCV005343355 pathogenic ALG8-related disorder 2024-08-29 no assertion criteria provided clinical testing The ALG8 c.544C>T variant is predicted to result in premature protein termination (p.Gln182*). To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. Nonsense variants in ALG8 are expected to be pathogenic for autosomal recessive congenital disorder of glycosylation (see for example, Schollen et al. 2004. PubMed ID: 15235028; Vuillaumier-Barrot et al. 2019. PubMed ID: 30420707). In addition, in a study of assessing the relationship between truncating ALG8 variants and polycystic kidney disease (PKD), individuals who are heterozygous for ALG8 pathogenic or likely pathogenic variants were shown to have increased risk of a mild (atypical) cystic kidney disease phenotype on imaging (Apple et al. 2023. PubMed ID: 36574950). For autosomal dominant polycystic liver disease with or without kidney cysts, currently there is limited evidence to support the gene-disease relationship (https://search.clinicalgenome.org/kb/genes/HGNC:23161). Therefore, this variant is interpreted as pathogenic for autosomal recessive congenital disorder of glycosylation while the clinical significance of this variant is uncertain for autosomal dominant polycystic liver disease with or without kidney cysts.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.